Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gerresheimer Ord Shs GRRMF

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.


OTCPK:GRRMF - Post by User

Comment by frankmanon Nov 26, 2024 2:05pm
2 Views
Post# 36331751

RE:RE:RE:RE:RE:RE:RE:just a posting test

RE:RE:RE:RE:RE:RE:RE:just a posting test
Filing Transaction Insider Name Ownership Securities Nature of transaction Volume or Value Price
Date Date Type
Sep 12/24 Sep 11/24 Passin, James Direct Ownership Warrants 16 - Acquisition under a prospectus exemption 6,000,000 $0.15
Sep 12/24 Sep 11/24 Passin, James Direct Ownership Common Shares 16 - Acquisition under a prospectus exemption 6,000,000 $0.05


https://www.canadianinsider.com/node/7?menu_tickersearch=BIOV+%7C+BioVaxys+Technology
<< Previous
Bullboard Posts
Next >>